Healthy Clinical Trial
Official title:
Testing A Model of the Representational Knowledge Stored in the Human Prefrontal Cortex
This study will examine the underlying mental processes that determine how people understand
social behavior, remember information, and think. Language, planning, problem solving,
reasoning, social behavior, and memory are the critical parts of cognition that make up daily
life. This study will explore the association between performance on various experimental
tasks and day-to-day functioning.
Healthy normal volunteers and patients with certain kinds of brain damage (primarily focal or
degenerative lesions of the human prefrontal cortex) or psychiatric disorders may be eligible
for this study. Candidates with central nervous system trauma, disease or dysfunction will be
screened with a routine neurological examination and history.
Participants may be asked to complete written tests, sit in front of a computer monitor and
press a key to indicate a decision about what appears on the screen (for example, whether a
statement is accurate) and answer questions from a test examiner. A skin conductance response
(SCR) test may be done along with some of the cognitive tests. SCR uses electrodes (pieces of
metal attached to wires) placed on the fingers to measure the subject's emotional reaction to
a test. Participants may also do an evoked response test, in which the subject watches words
or scenes on a TV screen while his or her responses are recorded from electrodes placed on
the scalp (similar to an electroencephalogram). The tests will be scheduled for an average of
one session a week, with each session lasting from 30 minutes to 3 hours. Generally, 15
sessions will be scheduled over a 1-year period. Special arrangements will be made to
accommodate participants from out-of-town.
Participants may have a magnetic resonance imaging (MRI) scan of the brain. This test uses
radio waves and a strong magnetic field to picture structural and chemical changes in tissue.
For the procedure, the subject lies on a table in a space enclosed by a metal cylinder (the
scanner) for about 1 hour.
In addition, some study subjects will be invited to participate in a training study designed
to improve their planning or social behavior. Participation requires coming to NIH daily over
a 1- to 2-month period for 1 to 2 hours each visit.
The purpose of this protocol is to test a comprehensive model of the underlying knowledge representations stored in the human prefrontal cortex developed by the principal investigator. Utilizing a variety of standardized and experimental neuropsychological tasks and techniques, we will investigate hypotheses regarding the role of the dorsolateral prefrontal cortex in planning, problem-solving, and reasoning and the ventromedial prefrontal cortex in social cognition and emotional processing. We will ascertain the relationship between so-called "cold" cognitive processes such as planning and "hot" social processes such as attitude formation and specific brain regions within the prefrontal cortex. Besides cognitive paradigms, we will use skin conductance and event-related EEG recording techniques when subjects are performing selected cognitive tasks in order to determine the relationship between autonomic and central nervous system markers of emotional modulation and speed/duration of processing and task performance. The data we collect in this protocol will be of value in 1) Developing a model of the forms of knowledge representation stored in the human prefrontal cortex; 2) Developing outcome measures for drug and behavioral treatments for disorders of prefrontal cortex functions; and, 3) Developing biologically plausible computer models of the cognitive sub-components stored in the human prefrontal cortex that compose the complex skills referred to above. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |